Predictive Factors for Occlusal Changes in Obstructive Sleep Apnea Treatment With Mandibular Advancement Appliance

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse

About this trial

This research addresses obstructive sleep apnea syndrome (OSAS), affecting 6-12% of French adults, often treated with mandibular advancement devices (MADs). MADs may lead to occlusal modifications, causing a 50% treatment abandonment rate. The study employs surface electromyography to assess masticatory muscle activity before and during MAD use, correlating it with occlusal changes after 6 months. The primary goal is to determine dental displacement profiles post-6-month MAD treatment, providing insights for personalized care and minimizing treatment failures.

Eligibility criteria

Qualifiers

Patient with complete dentition (up to second molars)

Polysomnography or polygraphy

Diagnosis of OSA

Patient receiving OAM treatment at the Odontology Department of Toulouse University Hospital

Disqualifiers

Inability to provide informed consent

Pregnant or breastfeeding patient

Patient with curators, guardians, or legal protection

Trial design

Treatments tested in this trial

  • Mandibular Advancement Device

Treatment groups

118 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators